Mega Lifesciences PCL (BKK:MEGA)

Thailand flag Thailand · Delayed Price · Currency is THB
34.25
-3.75 (-9.87%)
Mar 2, 2026, 4:35 PM ICT
5.38%
Market Cap 33.13B
Revenue (ttm) 14.19B
Net Income (ttm) 1.91B
Shares Out 871.87M
EPS (ttm) 2.19
PE Ratio 17.33
Forward PE 14.21
Dividend 1.60 (4.21%)
Ex-Dividend Date Mar 9, 2026
Volume 1,986,814
Average Volume 1,593,360
Open 36.00
Previous Close 38.00
Day's Range 34.25 - 36.25
52-Week Range 24.30 - 40.00
Beta 0.27
RSI 38.86
Earnings Date Feb 24, 2026

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; diabetics; eyes, heart, and skin care; pain, sl... [Read more]

Sector Healthcare
Founded 1982
Employees 900
Stock Exchange Stock Exchange of Thailand
Ticker Symbol MEGA
Full Company Profile

Financial Performance

In 2025, Mega Lifesciences PCL's revenue was 14.19 billion, a decrease of -7.74% compared to the previous year's 15.39 billion. Earnings were 1.91 billion, a decrease of -4.99%.

Financial Statements

News

There is no news available yet.